Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

132
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
132
Management of Insomnia01:19

Management of Insomnia

223
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
223
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

239
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
239
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

183
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
183
Stages of General Anesthesia01:22

Stages of General Anesthesia

317
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
317
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

162
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition to seizure: ictal discharge is preceded by exhausted presynaptic GABA release in the hippocampal CA3 region.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2012
Same author

AccERK2, a map kinase gene from Apis cerana cerana, plays roles in stress responses, developmental processes, and the nervous system.

Archives of insect biochemistry and physiology·2012
Same author

[Research on the issues in the process of post-market surveillance for medical devices based on the typical case analysis].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2012
Same author

Effect of copper on the expression of IGF-1 from chondrocytes in newborn piglets in vitro.

Biological trace element research·2012
Same author

Fabrication of biomimetic high performance antireflective and antifogging film by spin-coating.

Journal of colloid and interface science·2012
Same author

Bispectral index monitoring prevent awareness during total intravenous anesthesia: a prospective, randomized, double-blinded, multi-center controlled trial.

Chinese medical journal·2012

Related Experiment Video

Updated: May 15, 2025

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

1.8K

Remazolam on postoperative cognitive dysfunction: A perspective.

Liang Zhang1, Qing-Hua Wang2, Yi Qiu1

  • 1Department of Anaesthesiology, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Medicine
|May 5, 2025
PubMed
Summary

This review explores how remazolam, a sedative, may increase the risk of postoperative cognitive dysfunction (POCD), especially in elderly or high-dose patients. Further research is needed to clarify this association and guide safe clinical use.

Keywords:
associationpathogenesispharmacological actionpostoperative cognitive dysfunctionremazolam

More Related Videos

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

Related Experiment Videos

Last Updated: May 15, 2025

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

1.8K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Geriatrics

Background:

  • Postoperative cognitive dysfunction (POCD) is a significant concern, particularly in elderly patients.
  • Remazolam is a widely used sedative with potential neurological effects.
  • The relationship between remazolam and POCD requires further elucidation.

Purpose of the Study:

  • To critically review the existing literature on the association between remazolam administration and POCD.
  • To analyze the pathogenesis of POCD and the pharmacological mechanisms of remazolam.
  • To identify factors influencing the remazolam-POCD relationship and suggest future research directions.

Main Methods:

  • Systematic literature review and synthesis of pharmacological and clinical studies.
  • Analysis of research on POCD pathogenesis and remazolam's mechanism of action.
  • Critical evaluation of evidence regarding remazolam's impact on cognitive function post-surgery.

Main Results:

  • Remazolam, while a common sedative, may be associated with an increased risk of POCD.
  • Vulnerable populations, such as the elderly or those receiving high-dose/prolonged remazolam, appear more susceptible.
  • Research findings are variable, indicating a complex and nuanced relationship.

Conclusions:

  • Tailored guidelines for remazolam administration are necessary to mitigate POCD risk.
  • Holistic POCD prevention strategies, combining pharmacological and non-pharmacological approaches, are recommended.
  • Further rigorous research, including RCTs and longitudinal studies, is crucial to establish definitive evidence and guide clinical practice.